Perspective Therapeutics, Inc. Share Price
Equities
CATX
US46489V1044
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | +1.19% | +0.59% | +322.89% |
Sales 2024 * | - | Sales 2025 * | 63K 5.02M | Capitalization | 998M 79.58B |
---|---|---|---|---|---|
Net income 2024 * | -48M -3.83B | Net income 2025 * | -52M -4.15B | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 15,837 x |
P/E ratio 2024 * |
-19.6
x | P/E ratio 2025 * |
-16.5
x | Employees | 118 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.58% |
Latest transcript on Perspective Therapeutics, Inc.
1 day | +1.19% | ||
1 week | +0.59% | ||
Current month | +1.19% | ||
1 month | +32.81% | ||
3 months | +109.02% | ||
6 months | +546.39% | ||
Current year | +322.89% |
Managers | Title | Age | Since |
---|---|---|---|
Johan Spoor
CEO | Chief Executive Officer | 51 | 02/02/23 |
Mark Austin
DFI | Director of Finance/CFO | 37 | - |
Jonathan Hunt
DFI | Director of Finance/CFO | 57 | 02/02/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Heidi Henson
BRD | Director/Board Member | 58 | 31/05/23 |
Lori Woods
CHM | Chairman | 62 | 02/02/23 |
Director/Board Member | 58 | 02/02/23 |
Date | Price | Change | Volume |
---|---|---|---|
01/05/24 | 1.7 | +1.19% | 3,913,498 |
30/04/24 | 1.68 | +2.44% | 4,230,030 |
29/04/24 | 1.64 | +3.80% | 4,957,082 |
26/04/24 | 1.58 | -1.25% | 4,686,178 |
25/04/24 | 1.6 | -5.33% | 4,568,471 |
Delayed Quote Nyse, May 01, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+322.89% | 986M | |
-3.43% | 184B | |
-1.81% | 107B | |
-4.15% | 67.78B | |
+1.43% | 50.66B | |
+11.60% | 47.64B | |
+3.52% | 41.12B | |
+3.03% | 26.3B | |
+3.21% | 26.04B | |
+15.73% | 25.4B |
- Stock Market
- Equities
- CATX Stock